Subscribe By RSS or Email
Poised to Profit as Robotic Exoskeletons Go Mainstream

Poised to Profit as Robotic Exoskeletons Go Mainstream

Robotic exoskeletons have been a cornerstone of science-fiction movies, ranging from Aliens back in 1986 to Avengers: Age of Ultron earlier this year. While the military is actively developing the technology to help soldiers on the field, many companies are focused on hospitals rather than the battlefield. Robotic exoskeletons have the potential to dramatically improve […]

Promising Clinical Trials Coming in 2016 for IBD, Prostate Cancer and Spinal Cord Injuries

Promising Clinical Trials Coming in 2016 for IBD, Prostate Cancer and Spinal Cord Injuries

As 2015 winds to a close, a little reflection shows it was a huge year for biotechnology.  Of course, this year featured the biggest tax inversion deal ever with Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) agreeing to combine companies in a whopping $160 billion deal.  That mega-merger pushed the total for health and pharmaceutical […]

Oculus Has Made Significant Gains In The Dermatology Industry After Just One Year

Oculus Has Made Significant Gains In The Dermatology Industry After Just One Year

The following article was republished with permission from Edward Vranic, CFA’s Instablog. For years, Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) has tried to find a home for its Microcyn technology. Jim Schutz, the company’s COO until he took over the role as CEO last year has admitted that the company was “a mile wide and an […]

Recent Articles:

OxySure Adds Depth in Medical Supply Capability With New Agreement

OxySure Therapeutics Inc. (OTCQB: OXYS), a global leader and medical device innovator of life-saving emergency oxygen products based on its “oxygen from powder” technology, recently announced a new supply agreement with ORS Nasco, a division

2 Feb bnkl2

Bionik Labs Looks to Expand Awareness at BIO CEO & Investor Conference

Bionik Laboratories Corp. (OTCQX: BNKL), a pioneering medical device and robotics company with a focus on developing technoloiges and solutions for individuals with neurological disorders, recently announced that it would be presenting at the 18th

1 Feb bnkl2

Bionik Labs Works with IBM to Make ARKE™ Smarter

Bionik Laboratories Corp. (OTCQX: BNKL), a pioneering medical device and robotics company with a focus in developing technologies and solutions for individuals with neurological disorders, recently announced a collaboration with IBM (NYSE: IBM) to leverage

28 Jan regen_microscope

Pressure BioSciences’ SCIEX Deal Could Dramatically Accelerate Revenue

SCIEX, a global leader in life science analytical technologies, and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR), recently announced an exclusive co-marketing agreement with Pressure BioSciences, Inc. (OTCQB: PBIO).  PBIO is a worldwide leader

28 Jan regen_cells2

OncBioMune Patents a New Promising Approach to Chemotherapy

Chemotherapy compounds like paclitaxel and docetaxel have been used for years to treat cancer, but the caveat is that they indiscriminately kill both cancerous and normal cells. In order to solve this problem, researchers have

27 Jan bnkl2

Bionik Labs Will Give First Live Demo of ARKE™ GEN2 Exoskeleton

Bionik Laboratories Corp. (OTCQX: BNKL), a pioneering medical device and robotics company with a focus on developing technologies and solutions for individuals with neurological disorders, recently announced that it will present at the 2016 Colloquium

20 Jan Cardium Heart Regenerative Medicine Investment

BioLargo Closes Financing To Advance Its Novel Wound Care Products

BioLargo, Inc. (BLGO) recently announced that its subsidiary, Clyra Medical Technologies, secured a $5.75 million financing package for Its Advanced Wound Care Products.  Cash of $750,000 is earmarked for FDA Application and approval, and a

20 Jan regen_cells2

A Turnaround Story Wall Street Hasn’t Caught Onto Yet

With oil cratering and miners struggling amid depressed metal prices, there is no shortfall of “turnaround” talk on Wall Street for resource and energy companies that have suffered a beat-down in valuations in recent years. 

20 Jan Model615_wstrap_400square

3 Stocks Tackling Concussion Issues in Pro Athletes

The 2015 drama Concussion starring Will Smith follows the story of Dr. Bennet Omalu’s battle with the National Football League to acknowledge research on the brain damage suffered by professional football players. After examining the

15 Jan regen_microscope

Investors Flock to Pressure BioSciences as its Patented PCT Platform Goes Mainstream

Pressure BioSciences Inc. (OTCQB: PBIO) just announced that it exceeded its $5 million fundraising goal and approved the opening of an additional $1.25 million over-subscription amount in its PIPE offering. With growing revenue, a new

7 Jan Cardium Heart Regenerative Medicine Investment

BioLargo Secures Financing to Bring Wound Care Products to Market

BioLargo Inc. (OTCQB: BLGO), a developer of technologies designed to solve some of the world’s most important problems that threaten water, food, agriculture, health and energy, recently announced that it secured financing to support the

7 Jan samples

Innovation Sparks Advancement of New Treatments for Atopic Dermatitis

Even though the root cause of atopic dermatitis (AD), or eczema, remains a mystery, this is an exciting time in the dermatology space with innovation driving substantial advancements for the first time in decades.  As